List of Karus Therapeutics patents

Patents where

Current Assignee

Name

Karus Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11291669 Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent	Patent 11291669 was granted and assigned to Karus Therapeutics on April, 2022 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	11291669	April 5, 2022
‌ US Patent 10407435 Diheteroaryl histone deacetylase inhibitors and their use in therapy	Patent 10407435 was granted and assigned to Karus Therapeutics on September, 2019 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10407435	September 10, 2019
‌ US Patent 10442815 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Patent 10442815 was granted and assigned to Karus Therapeutics on October, 2019 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10442815	October 15, 2019
‌ US Patent 10035785 Phosphoinositide 3-kinase inhibitors	Patent 10035785 was granted and assigned to Karus Therapeutics on July, 2018 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10035785	July 31, 2018
‌ US Patent 9580442 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Patent 9580442 was granted and assigned to Karus Therapeutics on February, 2017 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	9580442	February 28, 2017
‌ US Patent 10513530 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Patent 10513530 was granted and assigned to Karus Therapeutics on December, 2019 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10513530	December 24, 2019
‌ US Patent 9938290 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Patent 9938290 was granted and assigned to Karus Therapeutics on April, 2018 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	9938290	April 10, 2018
‌ US Patent 9862685 Histone deacetylase inhibitors	Patent 9862685 was granted and assigned to Karus Therapeutics on January, 2018 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	9862685	January 9, 2018
‌ US Patent 8981087 Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors	Patent 8981087 was granted and assigned to Karus Therapeutics on March, 2015 by the United States Patent and Trademark Office.		Karus Therapeutics	United States Patent and Trademark Office	8981087	March 17, 2015
‌ US Patent 9663487 Phosphoinositide 3-kinase inhibitors	Patent 9663487 was granted and assigned to Karus Therapeutics on May, 2017 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	9663487	May 30, 2017
‌ US Patent 10668077 Compositions comprising phosphoinositide 3-kinase inhibitors and a second antiproliferative agent	Patent 10668077 was granted and assigned to Karus Therapeutics on June, 2020 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10668077	June 2, 2020
‌ US Patent 9981987 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Patent 9981987 was granted and assigned to Karus Therapeutics on May, 2018 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	9981987	May 29, 2018
‌ US Patent 10501478 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Patent 10501478 was granted and assigned to Karus Therapeutics on December, 2019 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10501478	December 10, 2019
‌ US Patent 10870624 Histone deacetylase inhibitors		Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10870624	December 22, 2020
‌ US Patent 10377764 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Patent 10377764 was granted and assigned to Karus Therapeutics on August, 2019 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10377764	August 13, 2019
‌ US Patent 9340503 Scriptaid isosteres and their use in therapy	Patent 9340503 was granted and assigned to Karus Therapeutics on May, 2016 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	9340503	May 17, 2016
‌ US Patent 10150763 Histone deacetylase inhibitors and their use in therapy	Patent 10150763 was granted and assigned to Karus Therapeutics on December, 2018 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10150763	December 11, 2018
‌ US Patent 9200007 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors	Patent 9200007 was granted and assigned to Karus Therapeutics on December, 2015 by the United States Patent and Trademark Office.		Karus Therapeutics	United States Patent and Trademark Office	9200007	December 1, 2015
‌ US Patent 9676765 Histone deacetylase inhibitors and their use in therapy	Patent 9676765 was granted and assigned to Karus Therapeutics on June, 2017 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	9676765	June 13, 2017
‌ US Patent 10533003 Polyheteroarl histone deacetylase inhibitors and their use in therapy	Patent 10533003 was granted and assigned to Karus Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Karus Therapeutics	Karus Therapeutics	United States Patent and Trademark Office	10533003	January 14, 2020
‌ US Patent 8865655 Depsipeptides and their therapeutic use			Karus Therapeutics	United States Patent and Trademark Office	8865655	October 21, 2014
‌ US Patent 8748458 Scriptaid isosteres and their use in therapy			Karus Therapeutics	United States Patent and Trademark Office	8748458	June 10, 2014
‌ US Patent 8614193 Depsipeptides and their therapeutic use	Patent 8614193 was granted and assigned to Karus Therapeutics on December, 2013 by the United States Patent and Trademark Office.		Karus Therapeutics	United States Patent and Trademark Office	8614193	December 24, 2013

23 results

0 selected

23 results

0 selected